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Abstract : 
Aquaglyceroporin-9 (AQP9) facilitates diffusion of water and energy 
substrates such as glycerol and monocarboxylates. AQP9 is present in plasma 
membrane and mitochondria of astrocytes and catecholaminergic neurons, 
suggesting that it plays a role in the energetic status of these cells. Using specific 
small interference RNA directed against AQP9 in astrocyte cultures, we showed 
that glycerol uptake is decreased which is associated with an increase in glucose 
uptake and oxidative metabolism. Our results not only confirm the presence of 
AQP9 in astrocytes but also suggest that changes in AQP9 expression alter glial 
energy metabolism. 
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Introduction: 
Aquaporins (AQPs) form a family of proteins with 13 members ubiquitously 
expressed in mammalian tissues. AQPs were first proposed to be involved in water 
diffusion and water homeostasis. A subgroup of AQPs are permeable to water, glycerol as 
well as other small solutes (e.g. monocarboxylates, copper, arsenite) and are named 
aquaglyceroporins (e.g. AQP9) (Badaut, 2010). In the brain, AQP9 was found in 
tanycytes of the mediobasal hypothalamus, in astrocytes and in catecholaminergic 
neurons (Arcienega et al., 2010; Badaut, 2010). At the subcellular level, AQP9 was found 
in the plasma membrane and in the internal mitochondrial membrane (Amiry-
Moghaddam et al., 2005). These immunohistochemical results are now debated because 
Rojek and collaborators reported the presence of AQP9 immunostaining in AQP9-/- mouse 
brain. The authors explained this result by the fact that this immunostaining is likely due 
to non-specific labeling with commercial antibodies (Rojek et al., 2007) and they 
questioned the presence of AQP9 in the brain. However, this result contrasts with several 
other studies using RT-PCR and in situ hybridization indicating the presence of AQP9 
mRNA, and revealing the presence of the AQP9 protein by western blot in rat and mouse 
brains (Arcienega et al., 2010; Mylonakou et al., 2009).  
AQP9 was also observed in the liver (Badaut et al., 2008) and its expression has 
been shown to be regulated by the physiological feeding state mediated by the insulin 
response element (IRE) present in the promoter of the gene (Kuriyama et al., 2002). 
AQP9 expression in liver is increased in rodent models of diabetes (Badaut et al., 2008), 
(Kuriyama et al., 2002). All these results support the concept that AQP9 facilitates 
glycerol use for neoglucogenesis during fasting periods (Badaut, 2010). The brain is 
known to be also involved in energy balance, and we have previously shown that the 
brain AQP9 expression is negatively regulated by insulin application, similarly to the 
observation in liver (Badaut et al., 2008). Furthermore, glycerol is already known to be 
used by brain tissue as a metabolite (Davis et al., 1981; McKenna et al., 1986; Seiler et 
al., 1969; Tildon and Roeder, 1980).  
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Based on these observations, we hypothesized that AQP9 could facilitate glycerol 
uptake in astrocytes and decreased AQP9 expression would affect astrocyte energy 
metabolism.  
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Results: 
1/ Reduced AQP9 expression after siRNA application. 
The application of the siAQP9 caused a significant decrease of AQP9 expression of 
67%±2% compared to CTL astrocyte cultures, treated with a non-targered siRNA (siGLO, 
p‹0.05)(Fig.1A, B). Astrocytes treated with siAQP4 exhibited a small but non-significant 
decrease of 33%±8% compared to CTL astrocyte cultures (Fig.1B). The hematoxylin 
staining (Fig.2A,B) and cell counting (Fig.2C) did not reveal any differences in cell density 
between CTL, siAQP4 and siAQP9-treated conditions, suggesting that the decrease in 
AQP9 protein level is not a consequence of cell death.  
 
2/ Functional consequences of AQP9 knockdown on glycerol uptake and 
astrocyte energy metabolism. 
14C-glycerol uptake was significantly decreased by 31%±6% (p‹0.05) in siAQP9 
treated cultures compared to CTL cultures (Fig.3A). Application of siAQP4 did not change 
glycerol uptake compared to the CTL group (Fig.3A). As glycerol is a putative energy 
metabolite for the central nervous system and potentially for astrocytes (McKenna et al., 
1986; McKenna et al., 2006), we then tested whether a decrease in AQP9 expression 
induced changes in glucose metabolism and in lactate release by astrocytes. Application 
of the siAQP9 induced a significant increase in 3H-2-deoxyglucose uptake that reached 
161%± 20% (P‹0.05) compared to CTL cultures (Fig.3B). The application of siAQP4 did 
not change the uptake of 3H-2-deoxyglucose (Fig.3B). Although glucose uptake was 
increased, the release of lactate was not changed under the same conditions (Fig.3C). 
Next, the possible changes in oxidative metabolism were studied using the MTT-staining, 
a marker of the oxidative pathway that is also used for cell number counting. Since we 
did not observe any changes in the number of cells, we supposed then that changes in 
MTT staining must be related to oxidative metabolism. Our experiments revealed that 
MTT-staining was reduced by 41%±8% (p‹0.05) in the siAQP4 condition and increased 
by 17%±9% (p‹0.05) in the siAQP9 treated cultures compared to the control (Fig.3D).  
 7 
Finally, the metabolic response of astrocytes induced by glutamate was then 
evaluated. Values for 3H-2-deoxyglucose uptake by astrocytes after glutamate application 
were normalized to the basal value for each experimental group to assess the response 
to glutamate on glucose metabolism for each condition (Fig.4A, B). Glutamate application 
induced a significant increase of 3H-2-deoxyglucose uptake (Fig.4A), which is paralleled 
by an increase in the release of lactate into the extracellular space in the 3 groups 
(Fig.4B). The metabolic response to glutamate application in astrocytes does not appear 
to be altered by the application of siAQP4 or siAQP9. 
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Discussion: 
In the brain, AQP9 expression was described in astrocytes and in catecholaminergic 
neurons by several groups, although recent results obtained with AQP9-KO mice 
questioned the presence of this channel protein in the brain. Using siRNAs against AQP9 
on astrocyte cultures, we showed that a reduction in AQP9 expression induced a decrease 
in glycerol uptake and changes in astrocyte energy metabolism. For the first time, AQP9 
was shown to contribute in astrocytes to glycerol diffusion and indirectly to energy 
metabolism. In fact, glycerol is known to be an energy substrate for brain tissue and also 
for astrocytes (McKenna et al., 1986). Glycerol is an important intermediate that can 
enter in the glycerol phosphate shuttle, a pathway that has been suggested to take place 
in astrocytes (McKenna et al., 1986). An interesting observation reported in this study is 
that a decrease in AQP9 expression (and glycerol uptake) in astrocytes increased their 
glucose uptake (Fig.2B) and potentially their oxidative metabolism, measured with MTT 
staining. The increase in oxidative metabolism might help to restore NAD+/NADH and 
FAD/FADH2 balance, possibly perturbed by the decrease of glycerol uptake in siAQP9 
treated cultures. A decrease of glycerol uptake may affect the glycerol phosphate shuttle, 
which is essential for maintaining a favorable NAD+/NADH ratio in the cell. Therefore 
oxidative metabolism is increased to maintain this ratio stable. In addition, glycerol might 
be used by the astrocyte as an energy substrate and the decrease of glycerol availability 
after siAQP9 application is compensated by an increase in glucose uptake and oxidative 
metabolism. On the basis of the in vitro work reported here, it can be proposed that 
AQP9 in vivo might play a role in energy metabolism in astrocytes. 
Interestingly, despite such a possible implication in oxidative metabolism, AQP9 
expression does not appear to alter the glycolytic response of astrocytes to an external 
signal such as glutamate. Such an observation emphasizes the point that glycolytic and 
oxidative metabolism in astrocytes can be compartmentalized and are likely regulated 
differently (Bouzier et al., 1998; Zwingmann et al., 2001). 
AQP4 knockdown does not change the level of glycerol and glucose uptake. However, 
we observed a significant decrease in MTT staining (Fig.2) without significant cell death 
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(Fig.1), suggesting that oxidative metabolism is impaired when AQP4 is decreased. This 
unexpected result may be related to new observations that AQP4 facilitates CO2 diffusion 
through the cell membrane (Musa-Aziz et al., 2009). A decrease of AQP4 expression may 
decrease the diffusion of CO2 and affect the astrocyte intracellular pH. This may have 
direct consequences on mitochondrial physiology. Alternatively, AQP4 might facilitate O2 
diffusion and decreased AQP4 expression might limit the access of O2 to the 
mitochondrial respiratory chain. 
In summary, our data show that AQP9 is present in astrocytes and involved in 
energy metabolism, facilitating glycerol movements through the membrane. We 
previously described increase of AQP9 expression in astrocytes after stroke (Badaut et 
al., 2001; de Castro Ribeiro et al., 2006), suggesting that the extracellular increase of 
glycerol after brain injury (Bertrand et al., 1992; Frykholm et al., 2001) is possibly 
cleared by the astrocytes and used as energetic substrate. Interestingly, AQP4 is also 
linked with oxidative metabolism, since when its expression is decreased oxidative 
metabolism is changed. In other words, under pathological conditions, an increase in 
AQP4 expression might also help in O2 diffusion and oxidative pathway, in addition to 
water diffusion. 
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Material and Methods 
 
Astrocyte cultures and siRNA tests 
Astrocyte cultures were prepared from mouse neurospheres (Brunet et al., 2004). 
After dissociation of the neurospheres, cells were plated into 12-well tissue culture plates 
(Costar 3524, Corning, NY) for differentiation into astrocytes using Fetal Calf Serum 
(10%) that was added to the culture 4 days prior to siRNA experiments.  
AQP silencing protocol was adapted from (Badaut et al., 2011). Briefly, SMART-
pool®-siRNA (20nM, Dharmacon-Research) against AQP4 (siAQP4), AQP9 (siAQP9), non-
targeted siRNA (siGLO-RISC-free, control condition) were mixed with Dharmafect® 
(Dharmacon-Research), diluted 1:50 in Opti-MEM (Invitrogen) 20 minutes before to be 
added to the cell medium 4 days prior to perform the experiments. In the three groups 
(CTL, siAQP4, siAQP9) the level of AQP9 expression was confirmed by Western blot 
analysis.  
Western blot analysis 
Astrocyte cultures were harvested in cells lysis buffer (RIPA buffer, Cell signaling) 
and sonicated for 30 sec. Ten µg of protein were subjected to SDS-polyacrylamide gel 
electrophoresis on a 10% gel (Nupage, Invitrogen, Carlsbad, CA). Proteins were then 
transferred to a polyvinylidene-fluoride membrane (PerkinElmer, Germany). The blot was 
incubated with a polyclonal antibody against AQP9 (Chemicon, California, 1:1,000) and a 
monoclonal antibody against actin (Sigma, Switzerland, 1:25,000) in Odyssey-blocking 
buffer (LI-COR-Bioscience, Germany) overnight at 4°C. After washing, the membrane 
was incubated with two fluorescence-coupled secondary antibodies (1:10,000; anti-
rabbit-Alexa-Fluor-680nm, Molecular-Probes, Oregon and anti-mouse IR-Dye-800-nm, 
Roche, Germany) for 2 hours at room temperature. Fluorescence was measured using an 
infra-red scanner (Odyssey-LI-COR, Germany) (Badaut et al., 2011) and analyzed on 3 
separate cultures for each group. 
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Histology and image analysis 
Hematoxylin stained cells were automatically counted in 3 separate cultures for 
each group with 5-ROIs, each one containing 65 fields (422µm x 338µm) after setting up 
threshold and morphology parameters using Mercartor software (Explora-Nova, France).  
14C-glycerol uptake measurement  
Glycerol uptake was studied by incubating cultured cells with 14C-glycerol (1 µCi) 
and unlabeled glycerol (final concentration 2 mM, specific activity 0.5 µCi/µmol) in the 
presence or absence of HgCl2 (1 mM). Incubation took place at 37°C for 10 min in DMEM 
(D5030) at pH 7.4 and determination of non transporter-mediated uptake was performed 
at 4°C. Then, the cultures were washed with the same buffer at 4°C containing HgCl2 (1 
mM) to block AQP9. Cells were harvested in 500 µl of PBS buffer containing NaOH (0.1M) 
and triton X100 (1%) and radioactivity was measured by scintillation counting. Data 
presented are an average of 4 separate cultures for each group. 
3H-2-Deoxyglucose uptake measurement 
Glucose utilization was determined by measuring 3H-2-Deoxyglucose (2DG) 
uptake (Pellerin and Magistretti, 1994). The procedure was similar to the one described 
above for glycerol measurement except that 3H-2-DG (American-Radiolabeled-Chemicals) 
at 1 µCi/ml (specific activity 60 Ci/mmol) was used as a tracer. The incubation time was 
20 min and glutamate (200µM) was added together with the medium containing the 
tracer. To determine non-transporter-mediated uptake, incubation was performed at 4°C. 
Results, which represent glucose transporter-mediated uptake, were calculated by 
subtracting from total counts the portion which was not inhibited at 4°C. Data presented 
are an average of 5 separate cultures for each group. 
Lactate release measurement 
Supernatants from 2DG uptake experiments were collected to determine lactate 
production. Two 100µl aliquots for each supernatant were placed in a 96-well plate. To 
each well was added 100 µl of a solution containing lactate dehydrogenase 70U/ml (L-
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2500 Sigma, Buchs, Switzerland) and NAD 15mM (53-84-9, Acros organics, Geel, 
Belgium) in glycine-semicarbazide buffer 0.33M, pH 10. After 1 h at 37°C, plates were 
read at 340 nm to detect production of NADH. A standard curve with known 
concentrations of lactate was used to determine lactate concentrations, corrected for the 
amount of protein in the same culture well. Data presented are an average of 5 separate 
cultures for each group. 
MTT measurement 
Thiazolyl Blue Tetrazolium Bromide (MTT) staining was used to evaluate 
mitochondrial oxidative activity. MTT was prepared at 5mg/ml in PBS and added to the 
cell medium at a final concentration of 5 g/ml. Cells were collected in DMSO and 
formazan was measured at 595 nm (TECAN SUNRISE, Software Magellan). The intensity 
of staining is linearly related to oxidative activity. Data presented are an average of 4 
separate cultures for each group. 
Statistical analysis 
All data are presented as mean ± SEM and statistical analysis was carried out 
using GraphPad InStat version 3.05 (GraphPad Software, San Diego CA) and (Sigmastat, 
SPSS Inc.). A Kolmogorov and Smirnov-test was first performed to assess the Gaussian 
distribution of the data. Data which passed the test were analyzed with an ANOVA 
followed by Tukey-Kramer multiple comparison tests.  
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Figure legends  
 
Figure 1:  
A) Western blot for AQP9 exhibiting a specific band (red) around 30 kDa in CTL, 
siAQP4 and siAQP9 conditions. The specific band for actin (green) located at 42 
kDa, was used as a loading control for the 3 conditions. AQP9 intensity is 
significantly reduced in the siAQP9 condition compared to siAQP4 and CTL. In 
cultures treated with siAQP4, a decrease of AQP9 expression was observed, but 
did not reach significance when assessed quantitatively (see B) 
B)  Western blot quantification showing that AQP9 intensity is significantly 
decreased in the siAQP9 condition compared to siAQP4 and CTL (*, p<0.05) in 
three independent experiments. 
 
Figure 2:  
 
A and B) Hematoxylin staining of CTL and siAQP9 treated cultures did not show 
changes in cell density. Bar = 50 µm 
C) Quantification of cell density confirms the visual impression that siAQP4 and 
siAQP9 did not change cell numbers. 
 
Figure 3 
 
A) Glycerol uptake after application of non-targeted siRNA (CTL), siAQP4 and siAQP9. 
Glycerol uptake is significantly decreased in siAQP9 treated cultures compared to 
siAQP4 and CTL (*, p<0.05) 
B) Glucose utilization as assessed by 3H2-deoxyglucose uptake after application of 
non-targeted siRNA (CTL), siAQP4 and siAQP9. 3H2-deoxyglucose uptake was 
significantly increased in siAQP9 treated cultures compared to siAQP4 and CTL 
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C) No significant difference in lactate release was observed after application of non-
targeted siRNA (CTL), siAQP4 and siAQP9. 
D) MTT staining showed a significant decrease after application of siAQP4 compared
to non-targeted siRNA (CTL) (#, p<0.05). In contrast, application of siAQP9 
showed a significant increase of the MTT staining compared to non-targeted 
siRNA (CTL) (*, p<0.05). 
Figure 4 
A) Glutamate application induced an increase of 3H-2-deoxyglucose uptake in the 3 
groups that reached 154%±9% in CTL (non-targeted siRNA), 162%±9% in 
siAQP4 and 139%±12% in siAQP9 groups (*, p<0.05). 
B) Glutamate application induced enhancement of lactate release into the
extracellular space reached 157%±15% in CTL (non-targeted siRNA), 138%±24 
in siAQP4 and 155%±27% in siAQP9 groups (*, p<0.05). 
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